This page has moved. Click here to view.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Medical Library. Full Text Journals Medical Books Online. Physicians Drug Reference

D *Dacarbazine (DTIC) -- Depression -- de Quervain's tenosynovitis -- Desmosomes Desquamation, radiation-induced -- Diabetes mellitus Diabetes of youth, maturity onset (MODY) -- Diarrhea Diascopy -- DiGeorge syndrome Digestion, defined -- Diphyllobothriasis Diphyllobothrium latum, megaloblastic anemia from -- DNA probes DNA repair genes -- Doxycycline Dracunculiasis (guinea worm infection) -- Drug development, for chemotherapy -- Drug eruptions, fixed -- Duodenal ulcers (DU) Dupuytren's contractures, in diabetes mellitus -- Dystonia Dystrophic calcification -- Dysuria, in urinary tract infections

 

Dacarbazine (DTIC)

for cancer [ch86 ¶81]

for melanoma [ch88 ¶18]

for soft tissue sarcomas [ch100 ¶22]

Dacryocystitis [ch28 ¶30]

Dactinomycin

alopecia from [ch86 ¶101]

for cancer [ch86 ¶70]

Danazol, for HTLV [ch192 ¶36]

Dandy-Walker syndrome [ch369 ¶7]

syringomyelia [ch373 ¶57]

D antigen [ch115 ¶8]

Dantrolene, for malignant hyperthermia [ch17 ¶40]

Dappe's stain [ch121 ¶13]

Dapsone [ch140 ¶83]

adverse effects [ch69 ¶12] [ch170 ¶49]

anemia from [ch308 ¶240]

for leishmaniasis [ch217 ¶35]

for leprosy [ch170 ¶47-¶49] [ch172 ¶38-¶39] [ch172 ¶43] [ch172 ¶44] [ch172 ¶46]

metabolism [ch68 ¶72]

pharmacology [ch170 ¶48]

for Pneumocystis carinii [ch308 ¶154] [ch308 ¶303]

for relapsing polychondritis [ch326 ¶15]

Darier's sign [ch57 ¶94] [ch310 ¶42]

Dark-field examination, for syphilis [ch174 ¶40]

Darmbrand [ch148 ¶10]

Daunorubicin

for cancer [ch86 ¶69]

for myeloid leukemia, acute [ch112 ¶36]

Dawn phenomenon [ch334 ¶78]

Day-care centers

 

[see: Child-care centers]

Daytime sleepiness

evaluation [ch27 Table2]

and sleep apnea [ch264 ¶6]

DDAVP [ch115 ¶72]

for von Willebrand's disease [ch117 ¶24]

ddI

[see: Didanosine]

Deafness

 

[see also: Hearing loss]

congenital sensorineural, genetics [ch65 ¶124]

drug-induced [ch69 Table1]

familial, cardiovascular manifestations [ch235 Table1]

pure word [ch25 ¶19]

Death [ch1 ¶45-¶55]

defined [ch1 ¶50]

DNR orders [ch1 ¶56]

leading causes of [ch4 ¶15] [ch4 Table2]

mortality rates [ch4 Figure1] [ch4 ¶13]

infant [ch4 ¶15]

sudden cardiac [ch39]

 

[see also: Sudden cardiac death]

Debrancher deficiency (limit dextrinosis) [ch347 ¶6] [ch347 ¶23-¶32] [ch347 Table1] [ch383 ¶77]

treatment [ch347rx2]

Debré-Kocher-Sémélaigne syndrome [ch383 ¶106]

Decay-accelerating protein, and paroxysmal nocturnal hemoglobinuria [ch109 ¶111-¶112]

Decerebrate rigidity [ch24 ¶29]

Decision analysis in clinical practice [ch3 Figure3] [ch3 ¶23-¶30] [ch3 Table1]

Decision-making capacity

patients without [ch2 ¶10]

surrogates [ch2 ¶12-¶21]

Decontamination, for poisoning [ch391 ¶18-¶25]

gastrointestinal [ch391 ¶35-¶41]

topical [ch391 ¶42]

Decorticate rigidity [ch24 ¶29]

Decubitus roentgenograms, for abdominal pain [ch14 ¶29]

Decubitus ulcers [ch133 ¶11]

spinal cord injury and [ch373 ¶69]

Deep venous thrombosis (DVT) [ch248 ¶62-¶73]

from oral contraceptives [ch337 ¶118]

in pregnancy [ch7 ¶26]

and pulmonary embolism [ch261 ¶4] [ch261 ¶15]

 

[see also: Pulmonary embolism]

Deerflies [ch393 ¶64]

Defecation [ch42 ¶5]

Defecography [ch42 ¶66]

Defensins [ch62 ¶4]

Deferoxamine, for hemochromatosis [ch342 ¶28]

Defibrillator/cardioverter

 

[see: Cardioverter/defibrillator]

Dehydration test, for diabetes insipidus [ch330 ¶33-¶41]

Dehydroepiandrosterone (DHEA) [ch332 ¶2] [ch332 ¶31]

 

[see also: Adrenal androgens]

and hair growth [ch53 ¶2]

metabolism and excretion [ch332 ¶8-¶9]

Dehydrogenase deficiency, genetics [ch65 ¶4]

Déjerine-Roussy syndrome [ch23 ¶27]

Déjerine-Sottas disease [ch363 Table1]

Delavirdine [ch183 ¶54]

for HIV [ch308 ¶290]

Deletion mapping [ch65 ¶56]

Delirium

defined [ch24 ¶8]

drug-induced [ch69 Table1]

in the elderly [ch9 ¶27]

and incontinence [ch9 ¶35]

Delirium tremens [ch386 ¶47] [ch386 ¶52]

Delta agent

 

[see: Hepatitis D virus]

Delta-9-tetrahydrocannabinol (THC) [ch388 ¶12-¶13] [ch388 ¶15-¶16]

Delusional infestations [ch393 ¶31]

Demeclocycline, cutaneous reactions [ch56 ¶69]

Dementia [ch26] [ch367]

alcohol-induced persisting [ch386 ¶19]

ALS/parkinsonian/dementia complex of Guam [ch367 ¶28]

Alzheimer's disease [ch367 ¶1-¶11]

 

[see also: Alzheimer's disease]

approach to the patient [ch26ap1] [ch26 Table3]

confusion vs. [ch24 ¶46]

cortical basal degeneration [ch367 ¶22] [ch367 ¶26]

differential diagnosis [ch26 ¶11-¶34] [ch26 Table2]

diffuse Lewy body disease [ch367 ¶16]

diffuse white matter [ch367 ¶12]

EEG in [ch361 ¶14]

in the elderly [ch9 ¶27]

etiology [ch26 Table2]

evaluation [ch26 Table3]

frontal lobe [ch367 ¶22] [ch367 ¶25]

functional anatomy and [ch26 ¶5]

genetic disorders [ch363 Table1]

 

[see also: individual disorders]

history taking [ch26 ¶36]

Huntington's disease [ch367 ¶18-¶21]

laboratory tests [ch26 ¶38] [ch26 Table3]

multi-infarct [ch26 ¶14] [ch26 ¶36] [ch367 ¶12]

normal-pressure hydrocephalus (NPH) [ch367 ¶17]

Parkinson's disease [ch367 ¶24]

pathogenesis [ch26 ¶5-¶10]

physical examination [ch26 ¶37]

Pick's disease [ch367 ¶15]

posttraumatic [ch26 ¶29] [ch26 ¶36]

praecox [ch26 ¶33]

primary progressive aphasia [ch367 ¶22] [ch367 ¶27]

progressive supranuclear palsy [ch367 ¶22] [ch367 ¶23-¶24]

pugilistica [ch26 ¶29]

treatment [ch26rx1]

vascular [ch367 ¶12-¶14]

Demographic factors [ch4 ¶3-¶10]

age [ch4 ¶3]

gender [ch4 ¶4]

geography [ch4 ¶9]

race/ethnicity [ch4 ¶5]

sexual orientation [ch4 ¶8]

Demyelinating diseases [ch376]

acute disseminated encephalomyelitis (ADEM) [ch376 ¶74-¶81]

acute hemorrhagic leukoencephalitis (AHL) [ch376 ¶82-¶84]

multiple sclerosis [ch376 ¶2-¶74]

 

[see also: Multiple sclerosis]

Demyelinating polyneuropathies

acquired [ch381 ¶43-¶46]

acute [ch381 ¶36-¶39]

chronic [ch381 ¶41]

chronic acquired (CIPD) [ch381 ¶68]

subacute [ch381 ¶40]

Dendritic cells [ch305 ¶41]

abnormalities, in HIV disease [ch308 ¶90]

follicular [ch305 ¶42]

in Langerhans cell granulomatosis [ch259 ¶45]

Dendritic macrophages [ch62 ¶28]

Dengue hemorrhagic fever/dengue shock syndrome [ch199 ¶30] [ch200 ¶9] [ch200 ¶10] [ch200 ¶81] [ch200 ¶114-¶126] [ch200 Table4]

Dennie's line [ch55 ¶4]

Dental caries [ch31 ¶2-¶5]

Dental discoloration, drug-induced [ch31 ¶5] [ch69 Table1]

from tetracyclines [ch31 ¶5] [ch140 ¶109]

Dental diseases [ch31 ¶2-¶5]

infectious [ch31 ¶2-¶4]

and brain abscess [ch377 ¶47]

and sinusitis [ch30 ¶7]

systemic factors in [ch31 ¶5]

Dental procedures, endocarditis prophylaxis [ch126 ¶74]

Dental pulp disease [ch31 ¶3]

Dentatorubropallidoluysian atrophy (DRLA) [ch363 ¶38] [ch363 Table1] [ch363 Table2] [ch369 ¶28]

Deoxycorticosterone (DOC), adenomas secreting [ch332 ¶95]

Deoxyribonucleic acid

 

[see: DNA]

Deoxyribonucleotides [ch65 ¶14]

Dependent personality [ch385 ¶97]

Depression [ch385 ¶43-¶60]

adolescent

DSM-III diagnosis [ch8 Table5]

and suicide [ch8 ¶39]

agitated [ch385 ¶61]

associated with medical illness [ch385 ¶36-¶42]

in cancer patients [ch81 ¶23]

clinical manifestations [ch385 ¶43-¶47] [ch385 Table5]

and cortical deficits [ch25 ¶54]

drug-induced [ch69 Table1]

dysthymic disorder [ch385 ¶45]

in the elderly [ch9 ¶27] [ch9 ¶31]

treatment [ch9rx1]

etiology and pathogenesis [ch385 ¶48-¶52]

headaches and [ch15 ¶37]

and incontinence [ch9 ¶39]

major [ch385 ¶43-¶44]

criteria [ch385 Table5]

and pain [ch12 ¶35]

seasonal affective disorder [ch385 ¶47]

sleep disorders and [ch27 ¶58]

smoking and [ch389 ¶29]

treatment [ch385 Figure3] [ch385rx6] [ch385 Table6] [ch385 Table7] [ch385 Table8]

unipolar [ch385 ¶47]

in women [ch6 ¶27]

 

D *Dacarbazine (DTIC) -- Depression -- de Quervain's tenosynovitis -- Desmosomes Desquamation, radiation-induced -- Diabetes mellitus Diabetes of youth, maturity onset (MODY) -- Diarrhea Diascopy -- DiGeorge syndrome Digestion, defined -- Diphyllobothriasis Diphyllobothrium latum, megaloblastic anemia from -- DNA probes DNA repair genes -- Doxycycline Dracunculiasis (guinea worm infection) -- Drug development, for chemotherapy -- Drug eruptions, fixed -- Duodenal ulcers (DU) Dupuytren's contractures, in diabetes mellitus -- Dystonia Dystrophic calcification -- Dysuria, in urinary tract infections

 

De Quervain's Thyroiditis

Decubitus Ulcers

Deep Venous Thrombosis

Dehydroepiandrosterone (DHEA) Excess Syndromes

Delirium Tremens

Dengue Fever

Dense Deposit Disease

Depigmenting Agents

Depression, Drug-induced

Depression

Dermal Fillers

Dermatitis Herpetiformis

Dermatofibroma

Dermatofibrosarcoma Protuberans

Dermatological Manifestations of Gastrointestinal Disease

Dermatomyositis and Polymyositis

Dermatosis Papulosa Nigra

Dermoid Tumors

Desert Fever

Detergent Worker's Disease

Di George Syndrome

Diabetes Insipidus

Diabetes Mellitus, Type II

Diabetes Mellitus

Diabetes Mellitus, Type I

Diabetic Nephropathy

Diabetic Ketoacidosis

Diabetic Ulcers

Diaphragm Disorders

Diaphragmatic Paralysis

Digital Mucous Cyst

Digitalis Toxicity

Dimercaprol Poisoning

Diphyllobothriasis

Dipylidiasis

Disseminate and Recurrent Infundibular Folliculitis

Disseminated Intravascular Coagulation (DIC)

Dissociative Disorders

Diverticulitis

Donovanosis

Drug Eruptions (Lichenoid)

Drug Abuse, Intravenous

Drug-Induced Bullous Disorders

Drug-Induced Lupus Erythematosus

Drug-Induced Pseudolymphoma Syndrome

Drug Eruptions (Exanthemic Drug Eruptions)

Drug Eruptions (Lichenoid)

Drug-Induced Lupus Erythematosus

Drug Eruption (Phototoxic)

Dubin-Johnson Syndrome

Dumping Syndrome

Duodenal Ulcers

Duodenal Diverticula

Dupuytren's Contracture

Dysbetalipoproteinemia

Dysfibrinogenemia

Dysfunctional Uterine Bleeding

Dysgenesis, Reticular

Dysgerminomas, Ovarian

Dyshidrotic Eczema

Dyskeratosis Congenita

Dysmenorrhea

Dysosmia

Dystonia, Tardive

Dystrophin